Table 5.
Outcomes during the follow-up
| Outcomes | VASP-guided group | Control group | P-value |
|---|---|---|---|
| n = 241 | n = 240 | ||
| Cardiovascular death | 1(0.4) | 2(0.8) | 0.34 |
| MI | 1(0.4) | 2 (0.8) | 0.34 |
| TVR | 1(0.4) | 3(1.3) | 0.03 |
| Stent thrombosis | 1(0.4) | 1(0.4) | 0.21 |
| Systemic embolism | 1(0.4) | 2(0.8) | 0.34 |
| Stroke | 1(0.4) | 2(0.8) | 0.34 |
| All MACCE | 6(2.5) | 12(5.0) | 0.02 |
| TIMI major bleeding | 7(3.0) | 6(2.8) | 0.72 |
| TIMI minor bleeding | 37(15.3) | 23(9.7) | 0.03 |
Values are presented as n(%)
MACCE major adverse cardiovascular and cerebral event, MI myocardial infarction, TIMI thrombolysis in myocardial infarction, TVR target vessel revascularisation